Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis.

Purpose: Immune checkpoint inhibitors (ICI) are effective against various malignancies. However, adverse events including diarrhea and colitis can lead to significant morbidity and mortality. Recommendations for the management of ICI mediated diarrhea and colitis include steroids and biologics.